Works matching IS 02780232 AND DT 2023 AND VI 41 AND IP 1

Results: 27

Co‐mutation landscape and clinical significance of RAS pathway related gene mutations in patients with myelodysplastic syndrome.

Published in:

Hematological Oncology, 2023, v. 41, n. 1, p. 159, doi. 10.1002/hon.3099

By:

Ren, Yanling;
Lang, Wei;
Mei, Chen;
Luo, Yingwan;
Ye, Li;
Wang, Lu;
Zhou, Xinping;
Xu, Gaixiang;
Ma, Liya;
Jin, Jie;
Tong, Hongyan

Publication type:

Article

Cell of origin is not associated with outcomes of relapsed or refractory diffuse large B cell lymphoma.

Published in:

Hematological Oncology, 2023, v. 41, n. 1, p. 39, doi. 10.1002/hon.3098

By:

Desai, Sanjal H.;
Mwangi, Raphael;
Smith, Alexandra N.;
Maurer, Matthew J.;
Farooq, Umar;
King, Rebecca L.;
Cerhan, James R.;
Feldman, Andrew L.;
Habermann, Thomas M.;
Thompson, Carrie A.;
Wang, Yucai;
Ansell, Stephen M.;
Witzig, Thomas E.;
Nowakowski, Grzegorz S.

Publication type:

Article

Prognostic factors in patients with bone marrow hemophagocytosis and its association with hematologic malignancies.

Published in:

Hematological Oncology, 2023, v. 41, n. 1, p. 167, doi. 10.1002/hon.3097

By:

Jiang, Jing‐Gu;
Liu, Chia‐Jen;
Yeh, Chiu‐Mei;
Yang, Ching‐Fen;
Liu, Yao‐Chung;
Wang, Hao‐Yuan;
Ko, Po‐Shen;
Chen, Po‐Min;
Yu, Yuan‐Bin;
Gau, Jyh‐Pyng;
Tsai, Chun‐Kuang

Publication type:

Article

Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B‐cell lymphoma in the rituximab era.

Published in:

Hematological Oncology, 2023, v. 41, n. 1, p. 97, doi. 10.1002/hon.3096

By:

Vassilakopoulos, Theodoros P.;
Panitsas, Fotios;
Mellios, Zois;
Apostolidis, John;
Michael, Michalis;
Gurion, Ronit;
Ferhanoglu, Burhan;
Hatzimichael, Eleftheria;
Karakatsanis, Stamatios;
Dimou, Maria;
Kalpadakis, Christina;
Katodritou, Eirini;
Leonidopoulou, Theoni;
Kotsianidis, Ioannis;
Giatra, Hara;
Kanellias, Nick;
Sayyed, Ayman;
Tadmor, Tamar;
Akay, Olga Meltem;
Angelopoulou, Maria K.

Publication type:

Article

Competitive evolved sub‐clonal BCR::ABL1 and novel MSI2::PC fusion genes in myelodysplastic syndrome with isolated del(5q).

Published in:

Hematological Oncology, 2023, v. 41, n. 1, p. 178, doi. 10.1002/hon.3095

By:

Zhang, Yanqing;
Liu, Yang;
Wang, Tong;
Wang, Hui;
Chen, Xue;
Cao, Panxiang;
Ma, Xiaoli;
Liu, Mingyue;
Xu, Ping;
Bi, Hailiang;
Pan, Jiaqi;
Jiang, Yongfang;
Li, Xiaoyun;
Wang, Wei;
Liu, Hongxing

Publication type:

Article

Intensified conditioning regimens improved disease‐free survival and engraftment after unrelated single‐unit cord blood transplantation but not after matched sibling or matched unrelated donor allogeneic hematopoietic cell transplantation.

Published in:

Hematological Oncology, 2023, v. 41, n. 1, p. 147, doi. 10.1002/hon.3094

By:

Konuma, Takaaki;
Kanda, Junya;
Uchida, Naoyuki;
Nishijima, Akihiko;
Tanaka, Masatsugu;
Ozawa, Yukiyasu;
Sawa, Masashi;
Onizuka, Makoto;
Ota, Shuichi;
Maruyama, Yumiko;
Kanda, Yoshinobu;
Kawakita, Toshiro;
Ara, Takahide;
Eto, Tetsuya;
Nakamae, Hirohisa;
Kimura, Takafumi;
Fukuda, Takahiro;
Atsuta, Yoshiko

Publication type:

Article

Exosomal NAMPT from chronic lymphocytic leukemia cells orchestrate monocyte survival and phenotype under endoplasmic reticulum stress.

Published in:

Hematological Oncology, 2023, v. 41, n. 1, p. 61, doi. 10.1002/hon.3093

By:

Ni, Jing;
Zhang, Ju;
Liu, Jiatao;
Fan, Lulu;
Lin, Xiao;
Yu, Hanqing;
Sun, Guoping

Publication type:

Article

SARS‐CoV‐2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID‐19 cohort.

Published in:

Hematological Oncology, 2023, v. 41, n. 1, p. 128, doi. 10.1002/hon.3092

By:

Merli, Michele;
Ferrarini, Isacco;
Merli, Francesco;
Busca, Alessandro;
Mina, Roberto;
Falini, Brunangelo;
Bruna, Riccardo;
Cairoli, Roberto;
Marchetti, Monia;
Romano, Alessandra;
Cavo, Michele;
Arcaini, Luca;
Trentin, Livio;
Cattaneo, Chiara;
Derenzini, Enrico;
Fracchiolla, Nicola Stefano;
Marchesi, Francesco;
Scattolin, Annamaria;
Billio, Atto;
Bocchia, Monica

Publication type:

Article

The applicability of the Second Revision of the International Staging System for patients with multiple myeloma receiving immunomodulatory drugs or proteasome inhibitor‐based regimens as induction treatment: A real‐world analysis.

Published in:

Hematological Oncology, 2023, v. 41, n. 1, p. 139, doi. 10.1002/hon.3090

By:

Chen, Haimin;
Zhou, Nian;
Hu, Xiaohua;
Wang, Dongjiao;
Wei, Wei;
Peng, Rong;
Chen, Xiaoling;
Shi, Haotian;
Wu, Lixia;
Yu, Wenjun;
Zhao, Wenhao;
Zhou, Fan

Publication type:

Article

A phase 1/2, open‐label, multicenter study of isatuximab in combination with cemiplimab in patients with lymphoma.

Published in:

Hematological Oncology, 2023, v. 41, n. 1, p. 108, doi. 10.1002/hon.3089

By:

Carlo‐Stella, Carmelo;
Zinzani, Pier Luigi;
Sureda, Anna;
Araújo, Luis;
Casasnovas, Olivier;
Carpio, Cecilia;
Yeh, Su‐Peng;
Bouabdallah, Krimo;
Cartron, Guillaume;
Kim, Won Seog;
Cordoba, Raul;
Koh, Youngil;
Re, Alessandro;
Alves, Daniela;
Chamuleau, Martine;
Le Gouill, Steven;
López‐Guillermo, Armando;
Moreira, Ilídia;
van der Poel, Marjolein W. M.;
Abbadessa, Giovanni

Publication type:

Article

Circulating cell‐free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre‐analytical biases.

Published in:

Hematological Oncology, 2023, v. 41, n. 1, p. 50, doi. 10.1002/hon.3087

By:

Soscia, Roberta;
Della Starza, Irene;
De Novi, Lucia Anna;
Ilari, Caterina;
Ansuinelli, Michela;
Cavalli, Marzia;
Bellomarino, Vittorio;
Cafforio, Luciana;
Di Trani, Mariangela;
Cazzaniga, Giovanni;
Fazio, Grazia;
Santoro, Alessandra;
Salemi, Domenico;
Spinelli, Orietta;
Tosi, Manuela;
Terragna, Carolina;
Robustelli, Valentina;
Bellissimo, Teresa;
Colafigli, Gioia;
Breccia, Massimo

Publication type:

Article

Management of patients with lymphoma and COVID‐19: Narrative review and evidence‐based practical recommendations.

Published in:

Hematological Oncology, 2023, v. 41, n. 1, p. 3, doi. 10.1002/hon.3086

By:

Passamonti, Francesco;
Nicastri, Emanuele;
Di Rocco, Alice;
Guarini, Attilio;
Ibatici, Adalberto;
Luminari, Stefano;
Mikulska, Malgorzata;
Visco, Carlo

Publication type:

Article

Predictors of clinical evolution of SARS‐CoV‐2 infection in hematological patients: A systematic review and meta‐analysis.

Published in:

Hematological Oncology, 2023, v. 41, n. 1, p. 16, doi. 10.1002/hon.3084

By:

Carrara, Elena;
Razzaboni, Elisa;
Azzini, Anna Maria;
De Rui, Maria Elena;
Pinho Guedes, Mariana Nunes;
Gorska, Anna;
Giannella, Maddalena;
Bussini, Linda;
Bartoletti, Michele;
Arbizzani, Federica;
Palacios‐Baena, Zaira R.;
Caponcello, Giulia;
Maldonado, Natalia;
Rodríguez‐Baño, Jesús;
Visco, Carlo;
Krampera, Mauro;
Tacconelli, Evelina

Publication type:

Article

Autologous hematopoietic cell transplantation versus whole‐brain radiotherapy consolidation in primary central nervous system lymphoma: A systematic review and meta‐analysis.

Published in:

Hematological Oncology, 2023, v. 41, n. 1, p. 88, doi. 10.1002/hon.3083

By:

Epperla, Narendranath;
Reljic, Tea;
Chowdhury, Sayan Mullick;
Ferreri, Andrés J. M.;
Kumar, Ambuj;
Hamadani, Mehdi

Publication type:

Article

Association of cesarean section with risk of childhood leukemia: A meta‐analysis from an observational study.

Published in:

Hematological Oncology, 2023, v. 41, n. 1, p. 182, doi. 10.1002/hon.3070

By:

Yang, Yingzhu;
Yu, Chiyuan;
Fu, Rongrong;
Xia, Shishan;
Ni, Haixiang;
He, Yujing;
Zhu, Keying;
Sun, Qian

Publication type:

Article

Reply to "successful early use of anti‐SARS‐CoV‐2 monoclonal neutralizing antibodies in SARS‐CoV‐2 infected hematological patients—A Czech multicenter experience": A case series of SARS‐CoV‐2 Omicron infection and aggressive lymphoma in the Sotrovimab era

Published in:

Hematological Oncology, 2023, v. 41, n. 1, p. 213, doi. 10.1002/hon.3079

By:

Cassin, Ramona;
Rampi, Nicolo;
C, Fidanza;
Muscatello, Antonio;
Mariani, Bianca;
Noto, Alessandro;
Rossi, Francesca Gaia;
Baldini, Luca

Publication type:

Article

Long term outcomes of gastric mucosa‐associated lymphoid tissue lymphoma treated with radiotherapy: A multi‐center retrospective cohort study.

Published in:

Hematological Oncology, 2023, v. 41, n. 1, p. 71, doi. 10.1002/hon.3078

By:

Smith, Clinton D.;
Gupta, Sanjiv;
Sinn Chin, Yaw;
Thompson, Stephen R.

Publication type:

Article

Effects of the BTN162b2 mRNA COVID‐19 vaccine in humoral and cellular immunity in patients with chronic lymphocytic leukemia.

Published in:

Hematological Oncology, 2023, v. 41, n. 1, p. 120, doi. 10.1002/hon.3077

By:

Fiorcari, Stefania;
Atene, Claudio Giacinto;
Maffei, Rossana;
Mesini, Nicolò;
Debbia, Giulia;
Colasante, Corrado;
Pozzi, Stefano;
Barbieri, Emiliano;
Maccaferri, Monica;
Leonardi, Giovanna;
Potenza, Leonardo;
Luppi, Mario;
Marasca, Roberto

Publication type:

Article

DNA damage accumulation and repair defects in FLT3‐ITD acute myeloid leukemia: Implications for clonal evolution and disease progression.

Published in:

Hematological Oncology, 2023, v. 41, n. 1, p. 26, doi. 10.1002/hon.3076

By:

Lagunas‐Rangel, Francisco Alejandro

Publication type:

Article

The elderly prognostic index predicts early mortality in older patients with diffuse large B‐cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi.

Published in:

Hematological Oncology, 2023, v. 41, n. 1, p. 78, doi. 10.1002/hon.3081

By:

Cencini, Emanuele;
Tucci, Alessandra;
Puccini, Benedetta;
Cavallo, Federica;
Luminari, Stefano;
Usai, Sara Veronica;
Fabbri, Alberto;
Pennese, Elsa;
Marino, Dario;
Zilioli, Vittorio Ruggero;
Balzarotti, Monica;
Petrucci, Luigi;
Tafuri, Agostino;
Arcari, Annalisa;
Botto, Barbara;
Zanni, Manuela;
Hohaus, Stefan;
Sartori, Roberto;
Merli, Michele;
Gini, Guido

Publication type:

Article

Convalescent plasma in oncohematological patients.

Published in:

Hematological Oncology, 2023, v. 41, n. 1, p. 208, doi. 10.1002/hon.3069

By:

Focosi, Daniele;
Franchini, Massimo;
Joyner, Michael J.;
Henderson, Jeffrey P.;
Casadevall, Arturo

Publication type:

Article

High mortality in fully vaccinated hematologic patients treated with anti‐CD20 antibodies during the "Omicron wave" of COVID‐19 pandemic.

Published in:

Hematological Oncology, 2023, v. 41, n. 1, p. 205, doi. 10.1002/hon.3064

By:

Cattaneo, Chiara;
Masina, Lorenzo;
Pagani, Chiara;
Cancelli, Valeria;
Daffini, Rosa;
Tucci, Alessandra;
Rossi, Giuseppe

Publication type:

Article

Distribution of lymphoma subtypes in Ukraine according to the WHO 2016 classification.

Published in:

Hematological Oncology, 2023, v. 41, n. 1, p. 196, doi. 10.1002/hon.3061

By:

Kriachok, Iryna;
Stepanishyna, Yana;
Skrypets, Tetiana;
Shokun, Nazar;
Martynchyk, Arina;
Tytorenko, Iryna;
Aleksik, Olena;
Krotevych, Mykhailo;
Manni, Martina;
Federico, Massimo

Publication type:

Article

Diffuse large B‐cell lymphoma of the Waldeyer's ring: A U.S. population‐based survival analysis.

Published in:

Hematological Oncology, 2023, v. 41, n. 1, p. 192, doi. 10.1002/hon.3059

By:

Florindez, Jorge A.;
Lossos, Izidore S.;
Alderuccio, Juan Pablo

Publication type:

Article

Response to SARS‐CoV‐2 vaccination and antibodies persistence in multiple myeloma patients.

Published in:

Hematological Oncology, 2023, v. 41, n. 1, p. 210, doi. 10.1002/hon.3051

By:

Pettine, Loredana;
Bortolotti, Marta;
Fattizzo, Bruno;
Da Vià, Matteo C.;
Consonni, Dario;
Pompa, Alessandra;
Bolli, Niccolò;
Baldini, Luca

Publication type:

Article

Role of chemotherapy in the treatment of chronic lymphocytic leukemia in the era of targeted therapies in Italy. A Campus CLL network report.

Published in:

Hematological Oncology, 2023, v. 41, n. 1, p. 201, doi. 10.1002/hon.3047

By:

Ballotta, Laura;
Maccaferri, Monica;
De Paoli, Lorenzo;
Orsucci, Lorella;
Gottardi, Daniela;
Chiurazzi, Federico;
Reda, Gianluigi;
Moia, Riccardo;
Cuneo, Antonio;
Foà, Robin;
Marasca, Roberto

Publication type:

Article

Issue Information.

Published in:: Hematological Oncology, 2023, v. 41, n. 1, p. 1, doi. 10.1002/hon.3018
Publication type:: Article